Heparin-induced thrombocytopenia (HIT) is characterized by thrombocytopenia and
paradoxical hypercoagulability. HIT occurs when an antibody (“HIT antibody”) produced …

Given the major role of unfractionated heparin (UFH) for anticoagulation in hemodialysis
(HD), it is important to define the potential impact of immune heparin-induced …

This study was conducted to determine the incidence of heparin-induced thrombocytopenia
(HIT), an important complication in heparin therapy, in 154 hemodialysis patients, with …

Heparin-induced thrombocytopenia (HIT) is a syndrome caused by platelet-activating
antibodies that recognize complexes of platelet factor 4 (PF4) and heparin …

Heparin-induced thrombocytopenia (HIT) associated with severe thrombotic events is a well-
recognized complication of heparin therapy. The frequency of HIT varies widely in different …

Heparin-induced thrombocytopenia (HIT) is a clinicopathologic syndrome in which one or
more clinical events, usually thrombocytopenia or thrombosis, are temporally related to …

Routine laboratory measurement of peripheral platelets was introduced only in the 1970s,
and as such, the first published report of HIT complicated by thrombosis dates back to 1969 …

Heparin‐induced thrombocytopenia (HIT) is an uncommon but potentially life‐threatening
complication of heparin therapy. Hemodialysis and hemofiltration patients are regularly …

Heparin-induced thrombocytopenia (HIT) is a pathophysiological syndrome caused by
platelet-activating antibodies that recognize PF4/heparin complexes. The abrupt onset of …

Heparin-induced thrombocytopenia (HIT) is a relatively common complication of heparin
therapy, occurring in up to 5% of patients who receive this drug [1]. Two types of HIT are …